Systemic hypertension is not protective against chronic intraocular pressure elevation in a rodent model
Abstract High intraocular pressure is the most well documented glaucoma risk factor; however many patients develop and/or show progression of glaucoma in its absence. It is now thought that in some instances, ocular perfusion pressure (blood pressure – intraocular pressure) may be as important as in...
Guardado en:
Autores principales: | Anna K. van Koeverden, Zheng He, Christine T. O. Nguyen, Algis J. Vingrys, Bang V. Bui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f3d58fbb93f41b38c1fb16a30316add |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Dorota Pozarowska
Publicado: (2010) -
Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Makoto Aihara
Publicado: (2010) -
Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
por: Quaranta L, et al.
Publicado: (2015) -
Evaluation of intraocular pressure elevation after multiple injections of intravitreal ranibizumab
por: Yu AL, et al.
Publicado: (2014) -
Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Henny JM Beckers, et al.
Publicado: (2009)